In the US, Alosetron (alosetron systemic) is a member of the drug class serotoninergic neuroenteric modulators and is used to treat Diarrhea and Irritable Bowel Syndrome.
US matches:
- Alosetron
- Alosetron Hydrochloride
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A03AE01
CAS registry number (Chemical Abstracts Service)
0122852-42-0
Chemical Formula
C17-H18-N4-O
Molecular Weight
294
Therapeutic Categories
Antiemetic
Serotonin antagonist
Chemical Names
1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-
2,3,4,5-Tetrahydro-5-methyl-2-[(5-methylimidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one (WHO)
Foreign Names
- Alosetronum (Latin)
- Alosetron (German)
- Alosétron (French)
- Alosetrón (Spanish)
Generic Names
- Alosetron (OS: BAN)
- GR 68755X (IS: Glaxo)
- Alosetron Hydrochloride (OS: USAN, BANM)
- GR 68755C (IS: Glaxo)
Brand Names
- Lotronex
GlaxoSmithKline, United States; Prometheus, United States
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and
International Nonproprietary Names.